Cutaneous cryptococcosis mimicking Kaposi's sarcoma as the initial manifestation of disseminated disease

Related Experiment Videos

A Blauvelt¹, F A Kerdel

¹Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Florida 33136.

International Journal of Dermatology

|April 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Super-response to guselkumab treatment in patients with moderate-to-severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

The British journal of dermatology·2021

Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

The British journal of dermatology·2020

Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

See all related articles